NEUROLOGY 2004;63:1187-1192
© 2004 American Academy of Neurology
Hyperinsulinemia and risk of Alzheimer disease
Jose A. Luchsinger, MD,
Ming-Xin Tang, PhD,
Steven Shea, MD and
Richard Mayeux, MD
From the Taub Institute for Research of Alzheimer’s Disease and the Aging Brain (Drs. Luchsinger, Tang, and Mayeux), Gertrude H. Sergievsky Center (Dr. Mayeux), and Departments of Biostatistics (Dr. Tang) and Epidemiology (Drs. Shea and Mayeux), Joseph P. Mailman School of Public Health, Columbia University, New York; and Division of General Medicine, Department of Medicine (Drs. Luchsinger and Shea), Department of Neurology (Dr. Mayeux), and Department of Psychiatry (Dr. Mayeux), Columbia University College of Physicians and Surgeons, New York, NY.
Address correspondence and reprint requests to Dr. Richard Mayeux, Gertrude H. Sergievsky Center, PH-19, 630 West 168th St., New York, NY 10032; e-mail: rpm2{at}columbia.edu
Objective: To explore the association between fasting insulin levels and dementia.
Methods: Fasting insulin levels were measured from frozen sera using solid-phase chemiluminescent enzyme immunoassay in a sample of elderly subjects chosen at random from a cohort of persons aged 65 years and older from northern Manhattan. Dementia was diagnosed using standard methods. Neuropsychiatric testing was available on all subjects at each follow-up interval.
Results: A total of 683 subjects without prevalent dementia were followed for 3,691 person-years and 149 persons developed dementia (137 Alzheimer disease [AD], 6 dementia associated with stroke, 6 other). The risk of AD doubled in the 39% of the sample with hyperinsulinemia (HR = 2.1; 95% CI: 1.5, 2.9) and was highest in people without diabetes. The HR relating presence of hyperinsulinemia or diabetes in 50% of our sample to AD was 2.2 (95% CI: 1.5, 3.1). The risk of AD attributable to the presence of hyperinsulinemia or diabetes was 39%. The HR of AD for the highest quartile of insulin compared to the lowest was 1.7 (95% CI: 1.0, 2.7; p for trend = 0.009). Hyperinsulinemia was also related to a significant decline in memory-related cognitive scores, but not to decline in other cognitive domains.
Conclusions: Hyperinsulinemia is associated with a higher risk of AD and decline in memory.
Received February 28, 2004.
Accepted in final form June 4, 2004.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the October 12 issue to find the title link for this article.
Related Article
-
October 12 Highlights
Neurology 2004 63: 1146-1147.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
Z. T. Bloomgarden
The 6th Annual World Congress on the Insulin Resistance Syndrome
Diabetes Care,
November 1, 2009;
32(11):
e127 - e133.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Freude, M. M. Hettich, C. Schumann, O. Stohr, L. Koch, C. Kohler, M. Udelhoven, U. Leeser, M. Muller, N. Kubota, et al.
Neuronal IGF-1 resistance reduces A{beta} accumulation and protects against premature death in a model of Alzheimer's disease
FASEB J,
October 1, 2009;
23(10):
3315 - 3324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. E. Devore, M. J. Stampfer, M. M.B. Breteler, B. Rosner, J. Hee Kang, O. Okereke, F. B. Hu, and F. Grodstein
Dietary Fat Intake and Cognitive Decline in Women With Type 2 Diabetes
Diabetes Care,
April 1, 2009;
32(4):
635 - 640.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Fitzpatrick, L. H. Kuller, O. L. Lopez, P. Diehr, E. S. O'Meara, W. T. Longstreth Jr, and J. A. Luchsinger
Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Arch Neurol,
March 1, 2009;
66(3):
336 - 342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. P. Helzner, J. A. Luchsinger, N. Scarmeas, S. Cosentino, A. M. Brickman, M. M. Glymour, and Y. Stern
Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease
Arch Neurol,
March 1, 2009;
66(3):
343 - 348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Kuczynski, W. Jagust, H. C. Chui, and B. Reed
An inverse association of cardiovascular risk and frontal lobe glucose metabolism
Neurology,
February 24, 2009;
72(8):
738 - 743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Xu, C. Qiu, M. Gatz, N. L. Pedersen, B. Johansson, and L. Fratiglioni
Mid- and Late-Life Diabetes in Relation to the Risk of Dementia: A Population-Based Twin Study
Diabetes,
January 1, 2009;
58(1):
71 - 77.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Llovera, M. de Tullio, L. G. Alonso, M. A. Leissring, S. B. Kaufman, A. E. Roher, G. de Prat Gay, L. Morelli, and E. M. Castano
The Catalytic Domain of Insulin-degrading Enzyme Forms a Denaturant-resistant Complex with Amyloid {beta} Peptide: IMPLICATIONS FOR ALZHEIMER DISEASE PATHOGENESIS
J. Biol. Chem.,
June 20, 2008;
283(25):
17039 - 17048.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Rolandsson, A. Backestrom, S. Eriksson, G. Hallmans, and L.-G. Nilsson
Increased Glucose Levels Are Associated With Episodic Memory in Nondiabetic Women
Diabetes,
February 1, 2008;
57(2):
440 - 443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tsukuda, M. Mogi, J.-M. Li, J. Iwanami, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi
Diabetes-Associated Cognitive Impairment Is Improved by a Calcium Channel Blocker, Nifedipine
Hypertension,
February 1, 2008;
51(2):
528 - 533.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-Q. Zhao, F. G. De Felice, S. Fernandez, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein
Amyloid beta oligomers induce impairment of neuronal insulin receptors
FASEB J,
January 1, 2008;
22(1):
246 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tsukuda, M. Mogi, J.-M. Li, J. Iwanami, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi
Amelioration of Cognitive Impairment in the Type-2 Diabetic Mouse by the Angiotensin II Type-1 Receptor Blocker Candesartan
Hypertension,
December 1, 2007;
50(6):
1099 - 1105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Cummings, R. Doody, and C. Clark
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Neurology,
October 16, 2007;
69(16):
1622 - 1634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Scarmeas, J. A. Luchsinger, R. Mayeux, and Y. Stern
Mediterranean diet and Alzheimer disease mortality
Neurology,
September 11, 2007;
69(11):
1084 - 1093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Burns, J. E. Donnelly, H. S. Anderson, M. S. Mayo, L. Spencer-Gardner, G. Thomas, B. B. Cronk, Z. Haddad, D. Klima, D. Hansen, et al.
Peripheral insulin and brain structure in early Alzheimer disease
Neurology,
September 11, 2007;
69(11):
1094 - 1104.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Luchsinger, C. Reitz, B. Patel, M.-X. Tang, J. J. Manly, and R. Mayeux
Relation of Diabetes to Mild Cognitive Impairment
Arch Neurol,
April 1, 2007;
64(4):
570 - 575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Luchsinger, B. Patel, M.-X. Tang, N. Schupf, and R. Mayeux
Measures of Adiposity and Dementia Risk in Elderly Persons
Arch Neurol,
March 1, 2007;
64(3):
392 - 398.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Xu, C. Qiu, B. Winblad, and L. Fratiglioni
The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer's Disease
Diabetes,
January 1, 2007;
56(1):
211 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Young, A. G. Mainous III, and M. Carnemolla
Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort
Diabetes Care,
December 1, 2006;
29(12):
2688 - 2693.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Scarmeas, Y. Stern, R. Mayeux, and J. A. Luchsinger
Mediterranean Diet, Alzheimer Disease, and Vascular Mediation
Arch Neurol,
December 1, 2006;
63(12):
1709 - 1717.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Akomolafe, A. Beiser, J. B. Meigs, R. Au, R. C. Green, L. A. Farrer, P. A. Wolf, and S. Seshadri
Diabetes Mellitus and Risk of Developing Alzheimer Disease: Results From the Framingham Study
Arch Neurol,
November 1, 2006;
63(11):
1551 - 1555.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Luchsinger
A Work in Progress: The Metabolic Syndrome
Sci. Aging Knowl. Environ.,
June 28, 2006;
2006(10):
pe19 - pe19.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
T. Sato, N. Shimogaito, X. Wu, S. Kikuchi, S.-i. Yamagishi, and M. Takeuchi
Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease
American Journal of Alzheimer's Disease and Other Dementias,
May 1, 2006;
21(3):
197 - 208.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. M. Ryan, M. I. Freed, J. A. Rood, A. R. Cobitz, B. R. Waterhouse, and M. W.J. Strachan
Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes
Diabetes Care,
February 1, 2006;
29(2):
345 - 351.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Watson, M. A. Reger, L. D. Baker, M. J. McNeely, W. Y. Fujimoto, S. E. Kahn, E. J. Boyko, D. L. Leonetti, and S. Craft
Effects of Exercise and Nutrition on Memory in Japanese Americans With Impaired Glucose Tolerance
Diabetes Care,
January 1, 2006;
29(1):
135 - 136.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Manly, N. Schupf, M.-X. Tang, and Y. Stern
Cognitive Decline and Literacy Among Ethnically Diverse Elders
J Geriatr Psychiatry Neurol,
December 1, 2005;
18(4):
213 - 217.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Freude, L. Plum, J. Schnitker, U. Leeser, M. Udelhoven, W. Krone, J. C. Bruning, and M. Schubert
Peripheral Hyperinsulinemia Promotes Tau Phosphorylation In Vivo
Diabetes,
December 1, 2005;
54(12):
3343 - 3348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Fishel, G. S. Watson, T. J. Montine, Q. Wang, P. S. Green, J. J. Kulstad, D. G. Cook, E. R. Peskind, L. D. Baker, D. Goldgaber, et al.
Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and {beta}-Amyloid in Normal Adults
Arch Neurol,
October 1, 2005;
62(10):
1539 - 1544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Knopman, T. H. Mosley, D. J. Catellier, A. R. Sharrett, and for the Atherosclerosis Risk in Communities (ARIC)
Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort
Neurology,
September 27, 2005;
65(6):
876 - 881.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea, and R. Mayeux
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Neurology,
August 23, 2005;
65(4):
545 - 551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Okereke, S. E. Hankinson, F. B. Hu, and F. Grodstein
Plasma C Peptide Level and Cognitive Function Among Older Women Without Diabetes Mellitus
Arch Intern Med,
July 25, 2005;
165(14):
1651 - 1656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ramasamy, S. J. Vannucci, S. S. D. Yan, K. Herold, S. F. Yan, and A. M. Schmidt
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
Glycobiology,
July 1, 2005;
15(7):
16R - 28R.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Desai and G. T. Grossberg
Diagnosis and treatment of Alzheimer's disease
Neurology,
June 28, 2005;
64(12_suppl_3):
S34 - S39.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
